← Back to headlines
Legend Biotech Shares Decline After $226M Public Offering
Legend Biotech's shares experienced a slide following the pricing of its $226 million public offering at $29.35 per unit.
18 Jun, 05:57 — 18 Jun, 05:57
Sources
Showing 1 of 1 sources
